| Literature DB >> 32457306 |
Gang Huang1,2,3,4, Junbo Xu5,6,7,8, Tingjie Zhang5,6, Lin Cai5,6,7,8, Hanxiong Liu5,6,7,8, Xiuqiong Yu5,6,7,8, Jing Wu5,6,7,8.
Abstract
Hyperuricemia is a risk factor for cardiovascular metabolic diseases. However, in the very elderly, the relationship between hyperuricemia and the metabolic syndrome (MetS) is not yet clear. This study was aimed to investigate the potential association between hyperuricemia and MetS in community very elderly in Chengdu. In this cross-sectional study, 1056 very elderly in the community were enrolled. Serum uric acid (SUA), fast plasma glucose, triglycerides and high-density lipoprotein cholesterol were measured, and then MetS components were calculated. Logistic regression models were used to explore risk factors for MetS in the very elderly. Finally, 1035 participants were included in analysis whose ages ranged between 80 and 100 with a mean age of 83.6 ± 3.4 years. The mean SUA level was 356.2 ± 95.0 µmol/L. The estimated prevalence of MetS in the very elderly was 25.0% vs. 21.6% (international diabetes federation (IDF) criteria vs. Chinese guideline), which was significantly higher for women (IDF criteria:17.3% in men vs 33.6% in women, p < 0.001). Logistic regression has found that participants with hyperuricemia (SUA level > 416 µmol/L in men and > 357 µmol/L in women) had a higher risk (IDF criteria: odds ratio (OR): 2.136, 95% confidence interval(CI): 1.525-2.993, p < 0.001. Chinese guideline: OR: 1.769, 95%CI: 1.249-2.503, p = 0.001) of MetS in very elderly Chinese. MetS is common in the community of very elderly Chinese in Chengdu. Hyperuricemia is associated with MetS in general very elderly and lifestyle changing should also be considered in the very elderly.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32457306 PMCID: PMC7250884 DOI: 10.1038/s41598-020-65605-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of community very elderly Chinese in Chengdu.
| Number of MetS components | p value | ||||
|---|---|---|---|---|---|
| 0 (n = 72) | 1 (n = 328) | 2 (n = 348) | ≥ 3 (n = 287) | ||
| Age (yrs) | 83.9 ± 3.3 | 83.7 ± 3.5 | 83.6 ± 3.4 | 83.6 ± 3.4 | 0.551 |
| Current smoker, n(%) | 7(9.7) | 42(12.8) | 34(9.8) | 31(10.8) | 0.624 |
| Current drinker, n(%) | 4(5.6) | 27(8.2) | 30(8.6) | 25(8.7) | 0.844 |
| Hypertension | 16(22.2) | 152(46.3) | 200(57.5) | 178(62.0) | <0.001 |
| DM | 2(2.8) | 28(8.5) | 59(17.0) | 88(30.7) | <0.001 |
| Abdominal obesity | 0(0) | 46(14.0) | 235(67.5) | 257(89.5) | <0.001 |
| Antihypertensive | 11(15.3) | 129(39.3) | 170(48.9) | 160(55.7) | <0.001 |
| Antidiabetic | 1(1.4) | 18(5.5) | 41(11.8) | 70(24.4) | <0.001 |
| Lipid lowering | 1(1.4) | 22(6.7) | 32(9.2) | 31(10.8) | 0.040 |
| Diuretics | 1(1.4) | 20(6.1) | 26(7.5) | 21(7.3) | 0.237 |
| WC (cm) | 76.9 ± 6.9 | 80.0 ± 9.2 | 89.4 ± 9.0 | 94.1 ± 8.0 | <0.001 |
| BMI (kg/m2) | 19.9 (17.5,21.9) | 20.7 (18.9,23.1) | 23.5 (21.6,25.9) | 24.8 (22.9,27.3) | <0.001 |
| SBP (mmHg) | 120.0 (110.0,123.0) | 142.0 (129.0,157.0) | 148.0 (136.5,164.0) | 151.5 (140.0,166.8) | <0.001 |
| DBP (mmHg) | 69.0 (62.0,72.5) | 73.0 (64.0,81.0) | 74.0 (67.0,82.3) | 76.0 (68.0,83.0) | <0.001 |
| FBG (mmol/L) | 4.80 (4.42,5.24) | 4.90 (4.50,5.27) | 5.10 (4.67,5.80) | 6.00 (5.22,7.56) | <0.001 |
| TC (mmol/L) | 4.64 (4.22,5.23) | 4.77 (4.08,5.36) | 4.94 (4.21,5.56) | 4.88 (4.21,5.66) | 0.018 |
| TG (mmol/L) | 1.04 (0.84,1.30) | 0.99 (0.77,1.27) | 1.17 (0.89,1.48) | 1.76 (1.21,2.29) | <0.001 |
| LDL (mmol/L) | 2.42 (1.98,2.79) | 2.44 (1.95,2.93) | 2.57 (2.06,3.05) | 2.69 (2.26,3.26) | <0.001 |
| HDL (mmol/L) | 1.67 (1.45,1.92) | 1.65 (1.40,1.96) | 1.59 (1.34,1.93) | 1.27 (1.09,1.54) | <0.001 |
| SUA (µmol/L) | 324 (275.8,412.3) | 334.5 (287.8,401.5) | 344.0 (281.0,400.3) | 373.0 (313.0,440.8) | <0.001 |
| Creatinine (μmol/L) | 98.0 (87.0,115.5) | 97.5 (88.8,113.0) | 98.0 (86.0,114.8) | 97.5 (87.0,115.0) | 0.225 |
| e GFR, ml/(min∙1.73m2) | 59.0 (43.0,73.2) | 59.4 (51.0,69.3) | 57.5 (48.9,64.9) | 55.4 (46.1,65.0) | 0.467 |
Data are expressed as mean ± standard deviation for normal distributed continuous variables, median (interquartile range) for skewed continuous variables, or number (percentage) for categorical variables. BMI: body mass index; DBP: diastolic blood pressure; DM: diabetes mellitus; eGFR: estimated glomerular filtration rate; HDL: high-density lipoprotein; LDL: low-density lipoprotein; SUA: serum uric acid; SBP: systolic blood pressure; TC: total cholesterol; TG: triglyceride; WC: Waist circumference.
Estimated prevalences of metabolic syndrome and its components in community very elderly Chinese in Chengdu.
| IDF criteria | Chinese guideline | |||||
|---|---|---|---|---|---|---|
| Men | Women | p value | Men | Women | p value | |
| MetS (%) | 95 (17.3) | 165 (33.6) | <0.001 | 97 (17.8) | 127 (25.8) | 0.002 |
| Abdominal obesity (%) | 243 (44.5) | 375 (76.2) | <0.001 | 243 (44.5) | 307 (62.4) | <0.001 |
| High blood pressure (%) | 432 (79.1) | 398 (80.9) | 0.484 | 432 (79.1) | 398 (80.9) | 0.484 |
| Hypertriglyceridemia (%) | 106 (19.4) | 127 (25.8) | 0.013 | 106 (19.4) | 127 (25.8) | 0.013 |
| Low HDL cholesterol (%) | 49 (9.0) | 106 (21.5) | <0.001 | 48 (8.8) | 23 (4.7) | 0.012 |
| Hyperglycemia (%) | 191 (34.9) | 154 (31.3) | 0.233 | 135 (24.7) | 109 (22.2) | 0.371 |
HDL: high-density lipoprotein,IDF: international diabetes federation, MetS: metabolic syndrome.
Association between hyperuricaemia and metabolic syndrome using logistic regression models in community very elderly Chinese in Chengdu.
| Serum uric acid OR (95% CI) | Hyperuricemia OR (95% CI) | |
|---|---|---|
| Metabolic syndrome (IDF criteria) | 1.342 (1.102–2.305)* | 2.136 (1.525–2.993)* |
| Abdominal Obesity | 1.320 (1.151–2.412)* | 1.833 (1.204–2.792)* |
| High blood pressure | 1.120 (0.898–1.503) | 0.953 (0.615–1.477) |
| Hypertriglyceridemia | 1.303 (1.122–2.205)* | 1.843 (1.301–2.612)* |
| Low HDL cholesterol | 1.352 (1.182–2.967)* | 1.974 (1.292–3.017)* |
| Hyperglycemia | 1.242 (1.156–1.881)* | 1.330 (0.931–1.901) |
| Metabolic syndrome (Chinese guideline) | 1.215 (1.109–2.304)* | 1.769 (1.249–2.503)* |
| Abdominal Obesity | 1.306 (1.138–2.326)* | 1.550 (1.052–2.284)* |
| High blood pressure | 1.120 (0.898–1.503) | 0.953 (0.615–1.477) |
| Hypertriglyceridemia | 1.303 (1.122–2.205)* | 1.843 (1.301–2.612)* |
| Low HDL cholesterol | 1.121 (0.797–1.304) | 1.706 (0.566–2.046) |
| Hyperglycemia | 1.102 (0.898–1.602) | 1.114 (0.754–1.647) |
Adjusted for sex, body mass index, low-density lipoprotein, eGFR, cigarette smoking, total cholesterol, low-density lipoprotein, alcohol consumption and medications for hypertension, diabetes mellitus, and hyperlipidemia. eGFR: estimated glomerular filtration rate. HDL: high-density lipoprotein, IDF: international diabetes federation. *p < 0.05.
Figure 1ROC curves of SUA level predicting MetS. (A) SUA level predicting MetS according to the IDF criteria in the very elderly. The AUC value was 0.622 (95%CI: 0.581–0.663, p < 0.001). (B) SUA level predicting MetS according to the Chinese guideline in the very elderly. The AUC value was 0.606 (95%CI: 0.563–0.649, p < 0.001). (C) SUA level predicting MetS according to the IDF criteria in very elderly women. The AUC value was 0.669 (95%CI: 0618–0.721, p < 0.001). (D) SUA level predicting MetS according to the Chinese guideline in very elderly women. The AUC value was 0.650 (95%CI: 0.594–0.706, p < 0.001). AUC: area under curve, CI: confidence interval, IDF: international diabetes federation, MetS: metabolic syndrome, ROC: receiver operating characteristic, SUA: serum uric acid.